You know there’s money to be made in the global generic drug market.
But which countries are up, which are down and which are coming into their own? Which companies are working together, who’s suing whom and how could developments inside top industry players affect expansion for makers of generics and biologics?
Here are the answers you need today to identify the best —and safest — business prospects for the years ahead.
With original research, country-by-country comparisons and five-year market forecasts, this two-volume report gives you the power to identify — and seize — the best expansion opportunities around the globe.
Profiles of 12 countries and 27 leading generics and biologics companies
Companies. Volume I reveals the financial status, products and recent developments of players such as Actavis, Dr. Reddy’s, Hospira, Sanofi and Watson. It also analyzes the impact of global developments, including the FDA’s new user fee program, trends in EMA inspections, consolidations, M&As, patent actions and the imminent patent cliff.
Countries.Volume II takes you inside the generic drug markets of 12 countries. Make country-by-country comparisons — market size, product approvals, the regulatory environment, pricing and reimbursement, manufacturing capabilities and intellectual property policies.
Decision Support. You also get FREE online access to Espicom Interactive for full-text, cross-file searching, presentation-ready tables and graphics, a report-building tool, and instant translation into nine languages.
Buy now for instant access to the hard-to-find data, trends and analysis it takes to make the right decisions about global expansion, including:
In the decades-long tradition of Espicom research and analysis, the World Generic Market Report 2012 brings you ready-to-use statistics, primary source data, original research, insightful commentary and practical analysis available from no other single resource. There is no smarter starting point for identifying the best and safest business prospects among the global generic drug and biologics industry players.
Get Multi-user Access With The Electronic Books Library.
Save money with a license agreement allowing significant numbers of users access to an electronic version of this book. For multi-user access to multiple titles, FDAnews offers the Electronic Books Library – a personalized collection of FDAnews publications that is fully searchable. Contact customer service for a quote or more information.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 – Fax (703) 538-7676 – Toll free (888) 838-5578.
Copyright ©2013. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing